drugset / Trial / NCT01342497

Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study

NCT01342497 ↗

Phase 2 Unknown 60 enrolled Bridge BioResearch Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this Clinical Proof of Principle study is to evaluate the effect of BBR-012 on the healing of complicated diabetic foot ulcers.

Timeline

Start
2011-07
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject isoniazide Unknown — —

Indications